HERON THERAPEUTICS, INC.
HRTX · NASDAQ
Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs. Heron is developing novel, patient-focused solutions that apply its innovative science and technologies to already-approved pharmacological agents for patients suffering from pain or cancer.
Market Data
Price
$0.41
+0.01 (+1.55%)
Market Cap$76M
P/E Ratio—
EPS$—
52W High$2.30
52W Low$0.39
Beta1.71
Data from Finnhub · Updated Jun 15, 2026